original contributions nature publishing group Worldwide, the elderly population (≥65 years) is growing because of increased longevity and better treatment of morbidities. 1,2 With increasing age, renal function declines with ~0.4 ml/min/1.73 m 2 /year from the age of 18 years. 3 Beside this, in general the prevalence of risk factors that accelerate renal function decline (RFD), such as hypertension 4 and diabetes mellitus 5 are rising. Therefore, the prevalence of elderly patients with chronic kidney disease (CKD) and endstage renal disease has increased over the last decades and will continue to increase. 6 The demand for predialysis care in elderly CKD patients is growing due to this increasing number of elderly late-stage CKD patients. To formulate evidencebased treatment guidelines for elderly predialysis patients, further studies should focus on the effect of known risk factors for an accelerated progression of CKD in this specific population.
Background
In the growing elderly predialysis population, little is known about the effect of identified risk factors on the progression to end-stage renal disease. Therefore, we investigated the association of systolic (SBP) and diastolic blood pressure (DBP) with the start of renal replacement therapy (RRT), in elderly (≥65 years) compared with young (<65 years) predialysis patients.
METHodS
In the PREPARE-1 cohort, 547 incident predialysis patients, referred as part of the usual care to eight Dutch predialysis care outpatient clinics, were included (1999-2001) and followed until the start of dialysis, transplantation, death, or until 1 January 2008. The outcome was the start of RRT. All analyses were stratified for age; <65 years (young) and ≥65 years (elderly).
rESulTS
In young predialysis patients (n = 268) higher SBP (every 20 mm Hg increase) and high DBP (DBP ≥100 mm Hg compared with 80-89 mm Hg) were associated with a higher rate of starting RRT (adjusted hazard ratio (HR) (95% confidence interval) 1.21 (1.09;1.34) and 1.74 (1.16;2.62), respectively). However, in elderly predialysis patients (n = 240) only patients with SBP ≥180 mm Hg had an increased rate compared with patients with 140-159 mm Hg (adjusted HR 2.33 (1.41;3.87)). Furthermore, patients with DBP <70 or ≥100 mm Hg had an increased rate of starting RRT, independent of SBP, compared with patients with 80-89 mm Hg (fully adjusted HR 1.72 (1.01;2.94) and 2.05 (1.13;3.73), respectively).
original contributions

BP in Predialysis Patients: Elderly Versus Young
is lacking. Moreover, there are some indications that low BP may result in an accelerated RFD in elderly predialysis patients. Therefore, target BP levels may differ between the young and elderly. As a consequence, the aim of our study was to investigate the association of BP (SBP and DBP) with the start of renal replacement therapy (RRT; dialysis and transplantation) in patients with CKD stages IV and V on predialysis care, stratified into young (<65 years) and elderly (≥65 years) patients. Furthermore, we used the rate of RFD as secondary outcome.
METHodS
Study design and population. The PREdialysis PAtient REcord-1 (PREPARE-1) study is a follow-up study in which incident adult patients with CKD stages IV and V were included at referral to predialysis care between 1999 and 2001. Referral to these outpatient clinics of eight Dutch hospitals was indicated if patients were expected to need RRT within 1 year and if their estimated creatinine clearance was below 20 ml/min. Patients who spent less than 1 month on predialysis care and patients with prior RRT were excluded. The clinical course of predialysis patients was followed through the medical charts from the start of predialysis care until the start of dialysis, transplantation, death, lost to follow-up, or end of study (1 January 2008), whichever was earliest. Predefined data on demography, anthropometry, and clinical symptoms were extracted from medical charts at inclusion and at the end of follow-up. All available data concerning laboratory measurements during the whole predialysis period were extracted from the Hospital Information Systems until 1 January 2003. The study was approved by the Institutional Review Boards of the participating hospitals and conducted in concordance with Good Clinical Practice Guidelines.
Measurements and definitions. BP and the variables used for adjustment in the multivariable analyses were baseline values assessed at the first predialysis visit and measured according to the standard care applied in each individual outpatient clinic. In the Netherlands, the most standard procedures for measuring BP are the use of cuff occlusion of the arm, auscultation method, or occasionally the use of a device, with the patient in sitting position. Hypertension at baseline was defined as SBP ≥130 mm Hg or DBP ≥80 mm Hg, and further divided into modest controlled hypertension (SBP 130-149 mm Hg or DBP 80-89 mm Hg) and poor controlled hypertension (SBP ≥150 mm Hg or DBP ≥90 mm Hg). 26 Estimated glomerular filtration rate (eGFR) was calculated using the abbreviated Modification of Diet in Renal Disease formula, taking into account age, sex, race, and measured serum creatinine. 27 Baseline serum creatinine, hemoglobin, and proteinuria measurements were defined as the measurement closest to the start of predialysis care, within 90 days before and 14-30 days after the start.
Outcome. The outcome was the start of RRT during complete follow-up (until 1 January 2008). As a secondary outcome we used rate of RFD (ml/min/1.73 m 2 /month) during complete follow-up. Not for all included patients this decline was calculated during complete follow-up because eGFR measurements were only extracted until 1 January 2003 and 96 patients had not reached an endpoint on that date. However, it is reliable to assume that the RFD followed a linear pattern 28 before and after this date. The method used for the estimation of the rate of RFD has been described in detail previously. 13 In short, a linear regression line was fitted through the available eGFR measurements for each individual patient. The slope of this line expresses the monthly loss of eGFR.
Statistical analyses. Continuous data were expressed as mean (SD) and skewed data as median (boundaries of interquartile range). All analyses were performed after stratification for age (<65 and ≥65 years), and SBP and DBP were analyzed in categories and continuously, only when on the association was linear. The cutoff point of 65 years to define young and elderly patients was based both on literature and on the median age (63 years) in our cohort. The following categories were used for SBP (<120, 120-139, 140-159 (reference), 160-179, and ≥180 mm Hg) and for DBP (<70, 70-79, 80-89 (reference), 90-99, and ≥100 mm Hg). A Cox proportional hazard regression analysis was used to investigate the association of SBP and DBP with the start of RRT. In all analyses, mortality and lost to follow-up were censored events. For the secondary outcome rate of RFD, the crude median (interquartile range) rate of RFD was calculated for all categories used in the Cox proportional hazard regression analyses. We reported medians (interquartile range) because RFD was not normally distributed. With a nonparametric test (Kruskal-Wallis) we tested whether the crude median RFD differed between the categories. For all Cox proportional hazard regression analyses, multivariable models were used to adjust for possible confounders such as age, sex, race, smoking, primary kidney disease, presence of cardiovascular comorbidities (cardiovascular disease: i.e., angina pectoris, coronary disease, myocardial infarction, left ventricular hypertrophy, and congestive heart failure), diabetes mellitus, malignancy, pulmonary disease, baseline eGFR, proteinuria level, and hemoglobin level. In the fully adjusted model investigating the association of DBP in categories with the start of RRT, we also included continuous SBP. This was done to check whether the effect of DBP was independent of SBP. For the two agecategories, the correlation between SBP and DBP was 0.628 in young and 0.500 in elderly patients. These values are both below the cutoff point of 0.700 used to check whether collinearity can be of great influence on the results of a regression model. 29 For body mass index, baseline eGFR, proteinuria level, and hemoglobin level there were subjects with missing values (n = 36, n = 63, n = 103, and n = 64, respectively). These missing values were imputed with multiple imputation (using five repetitions), 30, 31 a recommended technique where missing data for a patient are imputed by a value that is predicted by other known characteristics of this patient (i.e., demographic, anthropometric, clinical characteristics, and outcome). Furthermore, two sensitivity analyses were performed. First, we repeated all analyses using original contributions
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as determinants the average of the BP measurement at the start and at the end of follow-up, both SBP and DBP, divided into the same categories as mentioned above. Second, we repeated all analyses with SBP and DBP as single and quadratic continuous variables to test whether a U-shaped association was present. Including SBP and DBP as a continuous instead of a categorical variable in the model will result in more statistical power. All P values were two-tailed and P < 0.05 was considered statistically significant. Data were analyzed with PASW/ SPSS version 17 (SPSS, Chicago, IL).
rESulTS
Baseline characteristics
From the 547 incident predialysis patients included, 525 patients had no prior RRT and spent more than 1 month on predialysis care. SBP and DBP measurements at baseline were available for 508 patients who were included in our statistical analyses. Of these patients, 53% were younger than 65 years (young) and 47% were 65 years or older (elderly). Elderly compared with young patients had a higher SBP, lower DBP, higher eGFR, lower levels of proteinuria, and higher prevalence of comorbidities ( Tables 1 and 2) .
Of all patients, 92% were treated with antihypertensive drugs. Of the elderly patients, 45% received three or more different types of antihypertensive drugs, while among the young patients this was only 32% ( Table 2) . According to the type of medication, angiotensin converting enzyme-inhibitors (ACEi) were prescribed less often, angiotensin II-receptor blockers (ARBs) just as often, and other types of antihypertensive medication more frequently in elderly compared with young patients.
The median (interquartile range) follow-up time was 53 (23-99) weeks in young and 43 (20-99) weeks in elderly patients. For the time until the start of RRT these numbers were 50 (21-81) and 34 (18-89) weeks, respectively. During complete follow-up, 40% of the young patients started hemodialysis and 43% peritoneal dialysis, 7% were transplanted, 4% died, and 6% were lost to follow-up. In elderly patients, 46% started hemodialysis and 27% peritoneal dialysis, 0% was transplanted, 20% died, and 7% were lost to follow-up.
association of BP with the start of rrT
Young patients with SBP <120 mm Hg had a lower rate of starting RRT compared with young patients with SBP 140-159 mm Hg (adjusted hazard ratio (HR) 0.81 (95% confidence interval, 0.47;1.42), Table 3 ). Young patients with a SBP ≥180 mm Hg had a higher rate of starting RRT compared with young patients with SBP 140-159 mm Hg. Analyzing SBP in categories of 20 mm Hg resulted in the same pattern, every 20 mm Hg increase in SBP was associated with a higher rate of starting RRT (adjusted HR 1.21 (1.09;1.34)). Young patients with DBP ≥100 mm Hg had an adjusted 1.74 (1.16;2.62) fold increased rate of starting RRT than young patients with DBP 80-89 mm Hg ( Table 4) . This effect was diluted after including SBP in the model (Figure 1) .
Elderly patients with SBP <120 mm Hg had an increased rate of starting RRT compared with elderly patients with SBP 140-159 mm Hg (adjusted HR 2.82 (1.21;6.59), Table 3 ). However, the number of patients (n = 12) and events (n = 9) in the category SBP <120 mm Hg were too small to draw firm conclusions. In line with the results found for young patients with a high SBP, elderly patients with SBP ≥180 mm Hg had a higher rate of starting RRT, compared with the reference category (elderly patients with SBP 140-159 mm Hg). The association of DBP with the start of RRT in elderly patients showed a U-shaped pattern, because elderly patients with DBP <70 mm Hg (adjusted HR 1.60 (0.95;2.70)) or ≥100 mm Hg (adjusted HR 2.32 (1.33;4.04)) had an increased rate compared with elderly patients with DBP 80-89 mm Hg ( Table 4) . Including SBP in the model resulted in an even stronger U-shaped pattern (fully adjusted HR 1.72 (1.01;2.94) and 2.05 (1.13;3.73), respectively, Figure 1 ). original contributions
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Secondary outcome: rFd
The rate of RFD was available for 241 of the 268 (90%) young patients and 200 of the 240 (83%) elderly patients. As expected in young patients, the RFD was faster in patients with a higher rate of starting with RRT and slower in patients with a lower rate of starting with RRT ( Table 3 , P = 0.056 and 4, P = 0.065). RFD was also consistent with the rate of starting RRT in elderly patients with high SBP or DBP (Tables 3 and 4) . However, elderly patients with low SBP or DBP had a higher rate of starting RRT, but a slower RFD compared with the reference category. Across all BP categories, young compared with elderly patients had a twofold higher RFD.
Sensitivity analyses
The results remained comparable when taking the average of the SBP and DBP measurements at the start and at the end of follow-up as determinants, (10 and 12 young and 9 and 12 elderly patients had missing SBP and DBP measurements, respectively, at the end of follow-up and were therefore not included in this analysis The association of BP with the start of RRT was different in elderly (≥65 years) compared with young (<65 years) predialysis patients. In young predialysis patients, the rate of starting RRT increases with increasing SBP and with high DBP (≥100 mm Hg). Only elderly patients in the highest SBP category (≥180 mm Hg) had an increased rate of starting RRT. DBP showed a U-shaped association with the start of RRT in elderly predialysis patients because elderly patients with DBP <70 mm Hg or ≥100 mm Hg had a higher rate than patients with DBP 80-89 mm Hg. In conclusion, our analyses may indicate that in young predialysis patients a SBP and/or DBP as low as possible is beneficial. In elderly predialysis patients, a moderate increased SBP and DBP does not seem harmful. In this specific patient group only very high SBP and DBP, and low DBP were associated with a higher rate of starting RRT. Our study shows that in young predialysis patients high BP (SBP and DBP) accelerates the need to start with RRT, which is in line with several other studies performed in patients with CKD stages III-V. 13, 28, 32 As far as we know, no other study focused on this association in young compared with elderly well defined predialysis patients. We found a smaller effect size, crude and sex-and age-adjusted, of BP with the start of RRT in elderly compared with young predialysis patients. A possible explanation for this smaller effect size could be differences in the composition of factors that influence the decision to start with RRT between elderly and young patients, such as levels of eGFR, the presence of comorbidities, prognosis, anticipated quality of life, treatment burden, and preference of the patients. 6, 33, 34 This explanation seems plausible, as in the elderly predialysis patients the effect sizes became higher and more similar to the young predialysis patients after adjustment for factors influencing prognosis. Furthermore, we found that in elderly predialysis patients both low and high DBP accelerates the need to start with RRT. An association of low DBP with a faster RFD has also been found in the general 'healthy' elderly population. 15 Beside the elderly population, patients with cardiovascular disease also have a higher risk of another cardiovascular event when they have a low DBP. 35, 36 This harmful effect of DBP is probably due to the fact that a low DBP often original contributions
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coincide with the presence of cardiovascular comorbidities, such as congestive heart failure, myocardial infarction, and/or valvular heart disease. The PREPARE-1 study has some limitations. First, our results cannot be generalized to all patients with CKD stages IV and V, only to those patients receiving predialysis care in an outpatient clinic. However, for clinical practice our cohort is a very representative and relevant population. Second, SBP and DBP were collected only once at the start of predialysis care. This type of collection may lead to less precision and more variability of the BP measurements at baseline, and thereby may result in underestimated effects. Furthermore, during predialysis care BP could change due to treatment with antihypertensive drugs. Therefore, an analysis with time-varying BP would be interesting, but not possible with the data available (only BP measurement at the start and end of follow-up). Third, we used the complete follow-up in our cohort providing us with enough events in each of the five categories used in our analyses. However, previous analyses 13 showed that the association of BP with the start of RRT is somewhat diluted when complete instead of 6 or 12 months of follow-up is being used. Therefore, our results may be an underestimation of the real effect. Fourth, PREPARE-1 is an original contributions
observational study including predialysis patients when referred to an outpatient clinic. The clinical moment of referring differs between predialysis patients. Therefore, differences in prognosis at baseline could be present between patients with low and patients with high BP. A part of this problem was eliminated by adjustment for many confounders, but residual confounding could still be present. Unfortunately, we could not adjust for the RFD before the start of predialysis care. In elderly predialysis patients, both low and high DBP (U-shape) were associated, independent of SBP, with the start of RRT. Possible biological explanations for this U-shape are an accelerated RFD, the use of ACEi or ARBs, the presence of comorbidities, arterial stiffness and thereby congestive heart failure, and/or chronic hypoperfusion. First, RFD cannot be the complete explanation because our results in elderly patients showed that RFD was not always consistent with the rate of starting RRT. This is supported by our findings that the residual renal function at the start of RRT was highest in the elderly patients in the lowest DBP and SBP category. Second, a consensus has been reached that ACEi and ARBs can slow down RFD independent of BP lowering. In addition, ACEi and ARBs can also cause a temporary loss of renal function. However, after adjusting our analyses for ACEi and ARBs prescriptions the results did not change (data not shown). Possibly, frail elderly patients received a relatively higher dosage of ACEi and ARBs prescription compared with young patients. Unfortunately, in our cohort no data on dosages were available. Third, although the U-shaped association remained present after adjustment for the most important comorbidities, we could not control for severity and duration of comorbidities because these data were not available in the PREPARE-1 study. Therefore, differences in severity and duration of comorbidities still can be a part of the explanation for the U-shaped association of BP with the start of RRT. Fourth, arterial stiffness of the vessel wall, often accompanied with low DBP, is one of the pathophysiological changes becoming more pronounced with age. 37, 38 These changes can result in isolated systolic hypertension (which is defined as SBP ≥140 mm Hg and DBP <90 mm Hg) 26 and thereby an increased pulse pressure (marker for arterial stiffness), an increased afterload, left ventricular hypertrophy, reduced coronary perfusion, congestive heart failure, and altered or reduced blood supply to the tissues. 39 These clinical processes are often accompanied with renal damage. In our predialysis population, isolated systolic hypertension was present in 28% of the young and in 51% of the elderly patients. Also angina pectoris and myocardial infarction, consequences of reduced coronary perfusion, and left ventricular hypertrophy were more present in the elderly population. These numbers indicate that the presence of arterial stiffness was higher in elderly compared with young patients. However, both low and high DBP (U-shape) were associated with a higher rate of starting RRT, independent of SBP. Therefore, an increased pulse pressure could not be the entire explanation for the association of low DBP with start of RRT. Furthermore, after adjustment or stratification for the presence of left ventricular hypertrophy, angina pectoris, myocardial infarction, coronary disease, or congestive heart failure, the U-shaped association remained present in our cohort. However, congestive heart failure and a low BP often coincide, and therefore we cannot exclude the possibility that symptoms associated with congestive heart failure influence the clinical decision to start with RRT. Fifth, chronic hypoperfusion could be the cause of a higher rate of starting RRT in patients with low DBP. It is possible that in elderly predialysis patients low DBP, leading to hypoperfusion, may introduce overhydration and thereby lead to an earlier start of RRT. However, adjustment for overhydration did not change the results.
Our data showed that SBP and DBP at the start of predialysis care are differently associated with the start of RRT in elderly compared with young predialysis patients and this could have clinical implications. In young predialysis patients, it seems important to keep SBP and DBP as low as possible. Therefore, the current BP treatment target goal of <130/80 mm Hg 26, 40 in CKD patients, irrespective of age, seems correct for young predialysis patients. However, the very low percentage of patients on predialysis care achieving this treatment target level may suggest that it is very difficult to bring SBP and DBP into the range proposed in the guidelines. In elderly patients, only very high SBP and DBP were associated with the start of RRT. Therefore, targeting a blood pressure level of 130/80 mm Hg may not be necessary in elderly predialysis patients. This is of interest because antihypertensive drugs can cause a lot of side effects in elderly patients. Furthermore, elderly patients with extreme low DBP should be monitored carefully because they started RRT earlier than patients with moderate DBP levels. Our data are consistent with these clinical implications, but do not provide enough evidence to change the clinical practice due to the observational character of our study. Therefore, further studies are necessary to investigate whether a less stringent BP treatment target for elderly predialysis patients is just as beneficial or better as the current target to postpone the start of RRT. original contributions
